Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.

[1]  S. Moorjani,et al.  Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. , 1986, Metabolism: clinical and experimental.

[2]  G. Dagenais,et al.  Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  S. Srinivasan,et al.  Serum lipoproteins and endogenous sex hormones in early life: observations in children with different lipoprotein profiles. , 1985, Metabolism: clinical and experimental.

[4]  M. Herold,et al.  ESSENTIAL ROLE OF POST-HEPARIN LIPOPROTEIN LIPASE ACTIVITY AND OF PLASMA TESTOSTERONE IN CORONARY ARTERY DISEASE , 1985, The Lancet.

[5]  C. Glueck,et al.  Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. , 1984, Metabolism: clinical and experimental.

[6]  G. B. Phillips.  Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction. , 1984, The American journal of medicine.

[7]  L. Kuller,et al.  Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men. , 1984, The American journal of cardiology.

[8]  E. Borden,et al.  Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. , 1984, Metabolism: clinical and experimental.

[9]  M. Wheeler,et al.  Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin. , 1983, Acta endocrinologica.

[10]  S. Haffner,et al.  Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. , 1983, Metabolism: clinical and experimental.

[11]  C. Glueck,et al.  High and low density lipoprotein cholesterols in adolescent boys: relationships with endogenous testosterone, estradiol, and Quetelet index. , 1983, Metabolism: clinical and experimental.

[12]  W. Hazzard,et al.  Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. , 1982, Metabolism: clinical and experimental.

[13]  L. Kuller,et al.  Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. , 1981, The American journal of cardiology.

[14]  W. Vale,et al.  Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. , 1981, The New England journal of medicine.

[15]  C. Glueck,et al.  Hypertriglyceridemia and hypoalphalipoproteinemia in azoospermic and oligospermic young men: relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism. , 1981, Metabolism: clinical and experimental.

[16]  T. Dawber.  The Framingham Study: The Epidemiology of Atherosclerotic Disease , 1980 .

[17]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[18]  A. Bélanger,et al.  Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis. , 1980, Journal of steroid biochemistry.

[19]  A. Nordøy,et al.  Sex hormones and high density lipoproteins in healthy males. , 1979, Atherosclerosis.

[20]  S. Moorjani,et al.  Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. , 1979, Atherosclerosis.

[21]  R. Brookman,et al.  Lipids, lipoproteins, and sexual maturation during adolescence: the Princeton maturation study. , 1979, Metabolism: clinical and experimental.

[22]  V. Manninen,et al.  HORMONES AND HIGH-DENSITY LIPOPROTEINS , 1978, The Lancet.

[23]  R. Krauss,et al.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.

[24]  P. Steiner,et al.  Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. , 1978, Clinical chemistry.

[25]  W. Kannel,et al.  Menopause and Risk of Cardiovascular Disease: The Framingham Study , 1976 .

[26]  P. Alaupovic,et al.  Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. , 1976, Clinical chemistry.

[27]  Cox Bs.  Letter: Elective induction of labour. , 1975 .

[28]  Wynn,et al.  Mechanism of Hypertriglyceridaemia Associated with Contraceptive Steroids , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[29]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[30]  S. Margolis,et al.  Studies on human serum beta-1-lipoprotein. I. Amino acid composition. , 1966, The Journal of biological chemistry.

[31]  M. Burstein,et al.  Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum , 1960 .

[32]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  G. Getz,et al.  Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. , 1985, The Journal of clinical endocrinology and metabolism.

[35]  F. Labrie,et al.  Complete androgen blockade for the treatment of prostate cancer. , 1985, Important advances in oncology.

[36]  P. Gartside,et al.  Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. , 1983, Artery.

[37]  F. Labrie,et al.  New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens , 1983, The Prostate.

[38]  F. Labrie,et al.  New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. , 1982, Clinical and investigative medicine. Medecine clinique et experimentale.

[39]  E. Sotaniemi,et al.  Serum lipid levels and thromboembolic complications during estrogen therapy of prostatic cancer. , 1975 .

[40]  D. B. Zilversmit,et al.  Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. , 1950, The Journal of laboratory and clinical medicine.